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Introduction
The regulation of glucose uptake and its subsequent utilization is
critical for the maintenance of glucose homeostasis. It is well
established that glucose uptake is controlled by glucose trans-
porter (Glut-4) in the plasma membrane and the Glut-4 transloca-
tion to the membrane seems to be dependent on insulin-mediated
signalling pathways. Adipocytes of streptozotocin (STZ) induced
diabetic rats demonstrated reduction in insulin-stimulated glu-
cose transport function and cellular Glut-4 content [1] and evi-
dences show that the change in the glucose transporter content
is more specific for Glut-4 [2]. It was also reported that both Glut-
4 transport and content increase after insulin treatment [1, 2].
Dilated cardiomyopathy which is one of the major complications
during diabetes and it is characterized by depletion of adenosine
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Abstract
Homeostasis of blood glucose by insulin involves stimulation of glucose uptake by translocation of glucose transporter Glut-4 from
intracellular pool to the caveolar membrane system. In this study we examined resveratrol (RSV)-mediated Glut-4 translocation in the
streptozotocin (STZ)-induced diabetic myocardium. The rats were randomized into three groups: Control (Con), Diabetes Mellitus
(DM) (STZ 65 mg/kg b.w., i.p.) & DM + RSV (2.5 mg/kg b.wt. for 2 weeks orally) (RSV). Isolated rat hearts were used as per the
experimental model. RSV induced glucose uptake was observed in vitro with H9c2 cardiac myoblast cells. Decreased blood glucose
level was observed after 30 days (375 mg/dl) in RSV-treated rats when compared to DM (587 mg/dl). Treatment with RSV demon-
strated increased Adenosine Mono Phosphate Kinase (AMPK) phosphorylation compared to DM. Lipid raft fractions demonstrated
decreased expression of Glut-4, Cav-3 (0.4, 0.6-fold) in DM which was increased to 0.75- and 1.1-fold on RSV treatment as compared
to control. Increased Cav-1 expression (1.4-fold) in DM was reduced to 0.7-fold on RSV treatment. Increased phosphorylation of
endothelial Nitric Oxide Synthase (eNOS) & Akt was also observed in RSV compared to DM (P < 0.05). Confocal microscopy and co-
immunoprecipitation studies demonstrated decreased association of Glut-4/Cav-3 and increased association of Cav-1/eNOS in DM as
compared to control and converse results were obtained on RSV treatment. Our results suggests that the effect of RSV is non-insulin
dependent and triggers some of the similar intracellular insulin signalling components in myocardium such as eNOS, Akt through
AMPK pathway and also by regulating the caveolin-1 and caveolin-3 status that might play an essential role in Glut-4 translocation and
glucose uptake in STZ- induced type-1 diabetic myocardium.
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triposphate (ATP) stores is a consequence of impaired insulin
glucose uptake [3]. Insulin, a major regulator of glucose metab-
olism increases glucose transport by stimulating insertion of
Glut-4 from intracellular compartment to the cell surface [4] and
further transition of Glut-4 to the plasma membrane fraction
enriched by the caveolae [5]. Caveolae are small membrane
invaginations on the surface of the cells that participate in mem-
brane trafficking, sorting, transport and signal transduction.
These caveolae are enriched in sphingolipids and cholesterol and
form lipid rafts in the presence of structural proteins, the cave-
olins that serve as a marker for the caveolae [6, 7]. Mammalian
caveolin family proteins caveolin-1, 2 and 3 (Cav-1, 2 & 3) were
found to be the major components of caveolae [8]. Cav-3 or 
M-caveolin is expressed in the muscle where as caveolin-1 is
expressed in endothelial cells [9, 10]. Bucci et al. has shown that
caveolin-1 serves as a primary structural component of caveolae
and acts like a physiological inhibitor of eNOS [11] and further
demonstrated that caveolin-1 expression is up-regulated in dia-
betic non-obese diabetic (NOD) mice [11]. Both exercise and
insulin-mediated glucose uptake was found to be stimulated by
nitric oxide [12, 13, 14]. AMPK, a serine–threonine kinase was
shown to play an important role in regulation of cellular metabo-
lism and as a mediator of glucose metabolism [15]. Chen et al.
have demonstrated that activated AMPK phosphorylates eNOS
both in vitro and during ischaemia in rat hearts [16] and Li et al.
has shown the role of nitric oxide in AMPK-mediated glucose
uptake and Glut-4 translocation [17]. In the same study Li et al.
have also demonstrated that a relatively low concentration of
nitric oxide donors stimulated Glut-4 translocation and increased
glucose uptake in isolated heart papillary muscles [17]. We have
shown recently that resveratrol (RSV) (a polyphenolic compound
present in red wine) treatment increased myocardial function as
well as reduced blood glucose level that may be mediated
through nitric oxide [18]. We have also reported that RSV-
induced Akt-/eNOS-mediated protection in the hypercholestero-
laemic ischaemic myocardium [19]. Previous reports also
demonstrated that RSV enhances nitric oxide production in
endothelial cells [20] as well as in the heart [21]. It possesses
many other biologic activities, including an oestrogenic activity
[22], antioxidant activity [23], an anti-inflammatory function [24],
and a cancer chemopreventive property [25]. In conjunction with
the previous reports, in the present study we investigated the
mechanism involved in RSV-mediated regulation in glucose lev-
els in STZ-induced diabetic rats. We have also reported that
ischaemic preconditioning-mediated Glut-4 translocation is
mediated by differential activation of caveolins, eNOS and Akt that
helps in translocation of Glut-4 vesicles [26] to the plasma mem-
brane. Hence, in the present study we investigated the effect of
RSV on glucose homeostasis in STZ-induced diabetic rats in vivo
as well as RSV-mediated glucose uptake in H9c2 cells in vitro. In
our present study, we demonstrated for the first time that RSV-
induced Glut-4 translocation to the lipid rich fractions and its
association with caveolin-3 may be mediated by increased activa-
tion of AMPK, Akt, eNOS and decreased association of Cav-1/
eNOS resulting in glucose homeostasis in diabetic myocardium.
Materials and methods
Animals 
This study was performed in accordance with the principles of laboratory
animal care formulated by the National Society for Medical Research and
the Guide for the Care and Use of Laboratory Animals prepared by the
National Academy of Sciences and published by the National Institutes of
Health (Publication No. 85-23, revised 1985). The experimental protocol
was examined and approved by the Institutional Animal Care Committee of
the Connecticut Health Center (Farmington, CT). 
Experimental protocol 
All animals used in the study received humane care and treatment. Male
Sprague Dawley rats (275–300 g) were used for the study. Diabetes
was induced in the animals by a one time intraperitoneal administration
of streptozocin (STZ; Sigma, St Louis, MO) at a dosage of 65 mg/kg 
in citrate buffer. Control rats received an equal volume of citrate buffer
(i.p.). Blood was drawn from the rats by tail snip, and glucose levels
were measured using glucose monitoring system (Thera Sense, Inc.
Alameda, CA, USA) after 5 days of STZ administration. Rats with blood
glucose concentrations 300 mg/dl were considered to be diabetic.
Rats were randomly divided into three groups (n = 12 in each group):
(i ) Non-diabetic rats (control); (ii ) Diabetic rats (diabetes mellitus
[DM]); (iii ) DM+RSV (rats were treated with 2.5 mg / kg body weight
of RSV for 2 weeks orally). After the treatment period the animals 
were sacrificed and the hearts were excised and used for isolation 
of lipid raft fractions (n = 6) and immunohistochemical analysis 
(n = 6) respectively.
Isolated heart preparation 
(baseline sample preparation)
Rats were given an intraperitoneal bolus of heparin (500 IU/kg) and were
anaesthetized by the intraperitoneal administration of pentobarbital sodium
(80 mg/kg, Abbot, Baxter Health Care, Deep Field, IL). The hearts were 
perfused for 3 min. in langendorff mode for baseline samples to clear off
the blood as published earlier by Thirunavukkarasu et al.; 2007 [18]. After
the experimental protocol the left ventricular samples were flash frozen for
lipid raft fraction isolation and Western blot analysis. Another set of
animals was used for immunohistochemical analysis.
Cell Culture and 2-deoxy[3H]glucose uptake 
H9c2 cells were maintained in Dulbeccoís modified Eagleís medium
(DMEM). Glucose uptake was assayed by accumulation of
2-deoxy[3H]glucose according to Kotani et al. [27]. In brief, confluent
H9c2 cells in 12-well plates were washed twice with Dulbecco’s Buffer
(140 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1.5 mM KH2PO4, 8 mM
Na2HPO4 pH 7.4, 0.5 mM MgCl2) containing 0.2% bovine serum albumin
(BSA) and incubated in DB buffer for 30 min. at 37°C. Insulin was added
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to a final concentration 100 nM and cells were further incubated for 30 min.
that was used as the positive control. In separate wells, RSV was added
in concentrations of 25, 50 and 100 µM. The 50-µM dose was found to be
effective and this dose was further used to determine the time-point of
glucose uptake and 8 hrs of treatment was found to be effective. Finally,
DB buffer containing 0.2% BSA and 0.05 mM 2-deoxy[3H]glucose 
(0.5 µCi) was added to each well and after 5 min. of incubation, cells were
washed three times with ice-cold PBS and solubilized with 0.1% (w/v)
SDS. The radioactivity incorporated into the cells was measured with a liq-
uid scintillation counter. 
Isolation of caveolin-rich(lipid raft) fractions 
100–105 mg of tissue was homogenized in 2 ml of sucrose buffer (250
mM sucrose, 25 mM Tris (pH 7.4), 2 mM ethylenediaminetetraacetic acid
[EDTA], 150 mM NaCl, 1% Triton X-100, and protease inhibitor cocktail)
according to the modified protocol of Liu et al. [28] using a Polytron
homogenizer and the procedure was followed according as shown earlier
by Koneru et al. [26]. In brief, 5%, 30% and 80% sucrose solution were
made in TNE (Tris, NaCl and EGTA). The lysate was passed through a 23
g needle and was sonicated. Following sonication, 2 ml of 80% sucrose
was added and mixed to make the sucrose concentration to 40%. On the
top of this, 4 ml of 30% sucrose was added followed by 4 ml of 5%
sucrose solution. Thus, the total volume was made to 12 ml. The tubes
containing sucrose gradient was centrifuged at 33,000 rpm for 17 hrs.
Following centrifugation, the gradient was separated into 12 fractions of 1
ml each. Equal amount of protein was loaded for all the groups to perform
Western blot analysis. 
Immunoprecipitation for Cav-1/eNOS and
Cav-3/GLUT-4 association 
Caveolin-rich fractions (fractions 4–6) were used for immunoprecipitation.
Immunoprecipitation was performed with protein-A and protein-G
Sepharose beads from Amersham Biosciences (Piscataway, NJ) using a
polyclonal antibody against Cav-1 and Cav-3 monoclonal antibody from
Santa Cruz Biotechnology (Santa Cruz, CA). The procedure was carried out
according to manufacturer’s protocol. The caveolin-rich fractions (fractions
4–6) were immunoprecipitated with Cav-1 and Cav-3, which were re-blot-
ted with eNOS and GLUT-4, respectively.
Western blot analysis for p-AMPK, AMPK,
Cav-1, Cav-3, GLUT-4, p-eNOS, eNOS and
p-Akt and Akt 
To quantify the amount of Cav-1, Cav-3, GLUT-4 and phosphorylated
and non-phosphorylated AMPK, eNOS and Akt in the cytosolic and lipid
raft fractions, standard SDS-PAGE Western blot analysis was performed
with the use of polyacrylamide electrophoretic gels (7%, 10% and 12%;
acrylamide-to-bis ratios depending on the molecular weight of the pro-
teins) as described previously [19, 26]. The antibodies were purchased
(Cell Signaling Technology, Danvers, MA; Abcam, Cambridge, MA; and
Santa Cruz Biotechnology) and were used at manufacturer-recom-
mended dilutions.
Immunohistochemistry of Caveolin-1/3, 
Caveolin-1/eNOS and Caveolin-3/Glut-4
Paraffin-embedded tissue sections of 4 µm thick were used for immunohis-
tochemical analysis. The sections were deparaffinized using histoclear solu-
tion, 100%, 90%, 80% and 70% ethanol followed by phosphate buffered
saline (PBS) wash. Each step was carried for 5 min. Slides were placed in boil-
ing antigen retrieval buffer for 15 min. and was then allowed to cool at room
temperature for 20 min. Again, the slides were rinsed in PBS. The sections
were rinsed with 0.5% BSA in PBS for 20 min. The slides were blocked in
10% normal donkey serum with 1% BSA in PBS for 2 hrs. For Glut-4, the sec-
tions were rinsed and blocked with 0.4% triton-X 100 along with BSA.
Following blocking, the sections was incubated overnight with primary anti-
bodies for Cav-1 (SantaCruz Biotechnology) Cav-3, eNOS (BD Pharmingen,
San Diego, CA) and Glut-4 (Chemicon International, Temecula, CA) diluted
with 1% BSA in PBS overnight at room temperature. All primary antibodies
were diluted at 1:100 ratios. After overnight incubation the sections were
washed in PBS. The sections were rinsed with 0.5% BSA in PBS for three
times for 5 min. each. The sections were incubated with secondary antibod-
ies Alexa flour 555 anti-rabbit (for Cav-1), anti-goat (for Glut-4) and Alexa
flour 488 antimouse (for Cav-3 and eNOS) from Invitrogen, Eugene,
Oregon,USA The secondary antibodies were diluted with 1% BSA in PBS. The
sections were incubated in secondary for 2 hrs. After incubation the sections
were rinsed in PBS and mounted with citifluor mounting medium (Vector
Laboratories Inc, Burlingame, CA) as described previously [26]. The sections
were observed and pictures were taken using Confocal 410 microscope.
Statistical significance 
Results are expressed as mean ± standard deviation of the mean (±SD).
Differences between groups were tested for statistical significance by one-
way analysis of variance (ANOVA) followed by Bonferoniís correction, to test
for any differences between the mean values of all groups.
Results
Effect of resveratrol on glucose levels 
In our present study, as we have shown earlier [18] blood glucose
level (n = 12 in each group) was significantly increased in the dia-
betic rats when compared to non-diabetic rats (90 mg/dl) and
reduced on treatment with RSV. RSV therapy decreased the blood
glucose level significantly in RSV group (375 mg/dl) when com-
pared to DM group (>587mg/dl) after 30 days (Table 1).
Table 1 Effect of resveratrol treatment on blood glucose levels in
streptozotocin-induced diabetic rats
Groups Final (mg/dl) after 30 days
Control 90±2.3
Diabetic 587±43.4*
Diabetic + Resveratrol 375±18.6†
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Effect of resveratrol on 2-deoxy[3H]
glucose uptake 
We examined the dosage and time-dependent effect of RSV on glu-
cose (2-deoxy[3H] glucose) uptake in H9c2 cells as described pre-
viously in the method section. We have observed increased glucose
uptake in RSV-treated cells when compared to the normal control.
There was no significant increase in glucose uptake after 30 min. or
2 hrs of RSV treatment. However, we have observed a significant
increase (3.6-fold) in the glucose uptake after 8 hrs of treatment
with RSV (50 µm) as compared to the normal control. Cells treated
with insulin (100 nM, positive control) showed a significant increase
(4.9-fold) in the glucose uptake as early as 30 min. of treatment
(Fig. 1A). Insulin action was much faster as compared to RSV 
even at earlier time-points, but when incubated for longer time no
significant difference was observed so we have used shorter time-
point (30 min.). Furthermore, we have observed a significant
increase in the glucose uptake with increasing RSV concentrations
or dose as compared to the normal control. There was a significant
increase (3.9-fold) in glucose uptake at 50-µM concentration of RSV
when compared to the normal control. However, a further increase
in concentration of RSV treatment (100 µM) did not show any sig-
nificant difference (3.9-fold versus 4.2-fold) in glucose uptake with
respect to the 50 µM RSV-treated cells (Fig. 1B).
Effect of resveratrol on phosphorylation 
of Akt and AMPK levels 
Decreased phosphorylation of Akt was observed in the diabetic
group as compared to control group. RSV treatment increased
Fig. 1 (A) Graph represents the resveratrol
(RSV) (50 µm) mediated 2-deoxy[3H]glu-
cose uptake in H9c2 cardiac myoblast cells
in a time dependent manner. Insulin treat-
ment was used as the positive control.
*P < 0.05 represent significant difference in
comparison with control or non-treated
cells. (B) Graph represents the resveratrol-
mediated 2-deoxy[3H]glucose uptake in
H9c2 cardiac myoblast cells in a dose
dependent manner. 50 µM RSV treatment
has shown significant increase when com-
pared to 25 µM but no significant difference
was observed between 50 µM and 100 µM.
*P < 0.05 represent significant difference in
comparison with control or non-treated
cells. †P < 0.05 represent significant differ-
ence in comparison with 25 µM resveratrol-
treated cells.
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the phosphorylation of Akt (2-fold) as compared to DM group
(Fig. 2A). The phosphorylation of AMPK was found to be
reduced in diabetic group (0.5-fold) as compared to non-dia-
betic control. RSV treatment increased the phosphorylation 
of AMPK (2.3-fold) as compared to the non-treated diabetic
control. Density value of p-AMPK bands were normalized with
the AMPK value and expressed relative to control. Glyceraldehyde
Phosphate Dehydrogenase (GAPDH) was used as the loading
control and no significant difference was observed between the
groups (Fig. 2B).
Fig. 2 (A) Western blot represents the p-Akt
protein expression in caveolin/lipid raft frac-
tions in control, diabetes mellitus (DM) and
DM+RSV groups. Density value of p-Akt
bands were normalized to level of Akt and
expressed relative to control. Fractions 4–6
represent the membrane fractions and 8–12
represent the cytosolic fractions. (B) Protein
expression levels of p-AMPK in cytosolic
fractions of control, DM and DM+RSV
groups. Density value of p-AMPK bands
were normalized to level of AMPK and
expressed relative to control. GAPDH was
used as the loading control. n = 4 times
repeated experiments with equivalent
results. Graphs represent the quantitative
expression between the groups. *P < 0.05
represent significant difference compared
with control. †P < 0.05 represent significant
difference compared with DM.
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Effect of resveratrol on caveolin-1
and p-eNOS 
Caveolin-1 level was found to be decreased under RSV treat-
ment both in membrane (fractions 4–6) and cytosolic (fractions
8–12) fractions when compared to DM (Fig. 3A). Decreased
phosphorylation of eNOS was observed in the diabetic group as
compared to control group. RSV treatment increased the
phosphorylation of eNOS (1.5-fold) as compared to DM group
(Fig. 3B).
Effect of resveratrol on caveolin-3
and Glut-4 expression 
In contrast to caveolin-1 expression, caveolin-3 expression was
found to be increased in RSV when compared to diabetic group
(Fig. 4A). Caveolin-3 expression was increased both in membrane
(fractions 4–6) and cytosolic fractions (fractions 8–12) under RSV
treatment that is decreased in diabetic group. RSV treatment
increased the expression of Glut-4 in membrane as well as cytosolic
fractions when compared to DM. Increased Glut-4 in the membrane
Fig. 3A and B Western blot represents the
(A) caveolin-1 protein expression and (B) p-
eNOS, eNOS in caveolin/lipid raft fractions in
control, DM and DM+RSV groups. Fractions
4–6 represent the membrane fractions and
8–12 represent the cytosolic fractions.
Graphs represent the quantitative expres-
sion between the groups. n = 6 times
repeated experiments with equivalent
results. *P < 0.05 represent significant dif-
ference compared with control. †P < 0.05
represent significant difference compared
with DM.
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fraction in RSV group might be due to increased translocation of
Glut-4 following RSV treatment. Decreased expression of Glut-4
was observed both in membrane as well as cytosolic fractions in
the DM compared to non-diabetic control group (Fig. 4B).
Effect of resveratrol on Caveolin-3/Glut-4
and Caveolin-1/eNOS association
Immunoprecipitation assay was performed to show the associa-
tion of caveolin-3/Glut-4 and caveolin-1/eNOS in the caveolar-rich
fractions (fractions 4–6) during diabetes. Decreased association
of Glut-4 and Cav-3 was observed in diabetic group as compared
to control group (Fig. 5A). RSV treatment documented increased
association of Glut-4 and Cav-3 as compared to DM. The
increased Glut-4 translocation and its association with Cav-3 on
RSV treatment might have resulted in increased glucose uptake.
Immunoprecipitation of Cav-1 and immunoblotting with eNOS
clearly demonstrated that in diabetic group eNOS is significantly
associated with Cav-1 as shown in Figure 5B. During RSV treat-
ment we have observed dissociation of Cav-1 and eNOS that
might have resulted in increased phosphorylation of eNOS.
Fig. 4A and B Western blot represents the
(A) caveolin-3 and (B) Glut-4 protein expres-
sion in caveolin/lipid raft fractions in control,
DM and DM+RSV groups. Fractions 4–6
represent the membrane fractions and 8–12
represent the cytosolic fractions. Graphs
represent the quantitative expression
between the groups. n = 6 in each group.
*P < 0.05 represent significant difference
compared with control. †P < 0.05 represent
significant difference compared with DM.
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Fig. 5 (A) Immunoprecipitation with caveolin-3 and re-blot with Glut-4 in control, DM and DM+RSV groups. (B) Immunoprecipitation with caveolin-1 and
re-blot with eNOS in control, DM and DM+RSV groups. n = 6 in each group. P < 0.05 represent significant difference compared with control. †P < 0.05
represent significant difference compared with DM.
Fig. 6 Represents the rat cardiac
paraffin sections labelled with
immunofluorescence and visual-
ized using confocal microscopy in
control, DM and DM+RSV groups.
A, D and G represent red fluores-
cence labelled caveolin-1. B, E and
H represent the green fluorescence
labelled caveolin-3. C, F and I repre-
sent the merged photo of Cav-1 and
Cav-3. White arrows denote cave-
olin-1; Yellow arrows denote cave-
olin-3. The number of arrows rep-
resents the extent of expression of
either Cav-1 or Cav-3. No signifi-
cant co-localization (merged) was
observed between the caveolin-1
and caveolin-3. n = 6 in each group.
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Reduced eNOS phosphorylation in diabetic group as compared to
control might be due to increased Cav-1/eNOS interaction or asso-
ciation that possibly made eNOS unavailable for its activation. 
Immunohistochemical analysis of Cav-1/Cav-3,
Cav-1/eNOS and Cav-3/Glut-4 association 
Immunohistochemical analysis is shown in Figs 6–8 respec-
tively. The immunohistochemical analysis documented signifi-
cant increase in the expression of Cav-1 (stained in red in Fig.
6D) and decrease in the Cav-3 (stained in green in Fig. 6E) in the
membrane of DM as compared to control. However, no signifi-
cant co-localizaton of Cav-1/Cav-3 was observed in any of the
groups (Fig. 6C, F and I). On treatment with RSV, decreased
Cav-1 (Fig. 6G) expression and increased Cav-3 expression was
observed (Fig. 6H) as expected. Significant association of Cav-
1/eNOS in the membrane was observed in the diabetic group
(Fig. 7F) as compared to control (Fig. 7C). On RSV treatment
Cav-1/eNOS association was found to be decreased as com-
pared to the diabetic group (Fig. 7I). DM has shown decreased
Glut-4 translocation to the membrane and association with
caveolin-3 (Fig. 8F) as compared to control (Fig. 8C). On RSV
treatment, increased Glut-4 association with caveolin-3 was
observed as compared to diabetic group (Fig. 8I).
Discussion
In the present study, we report hypoglycaemic effect of RSV and
its role in regulation of myocardial Glut-4 translocation and glu-
cose uptake in STZ-induced type-1 diabetic rats. This study
shows that the RSV-mediated glucose uptake by modulating the
Cav-1 and Cav-3 status in diabetic myocardium is mostly non-
insulin related. We have observed increased translocation of
Glut-4 and its association with caveolin-3 and dissociation of
Cav-1/eNOS interaction in lipid raft fractions after RSV treat-
ment. We have also documented increased phosphorylation of
AMPK, eNOS and Akt on RSV treatment. From the results
Fig. 7 Represents the rat cardiac
paraffin sections labelled with
immunofluorescence and visualized
using confocal microscopy in control,
DM and DM+RSV groups. A, D and G
represent red fluorescence labelled
caveolin-1. B, E and H represent the
green fluorescence labelled eNOS. 
C, F and I represent the merged photo
which clearly shows the co-localiza-
tion of caveolin-1 / eNOS. n = 6 in
each group. White arrows denote
Caveolin-1, yellow arrows denote
eNOS and the white/yellow (merged)
arrow denotes the caveolin-1 and
eNOS association / co-localization.
The number of arrows represents the
extent of expression of either cav-1,
eNOS or the extent of co-localization.
The figure in the box represents the
magnified image demonstrating the
co-localization.
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obtained, we hypothesize that RSV-mediated Glut-4 transloca-
tion and glucose uptake might be AMPK /nitric oxide/ Akt medi-
ated and regulated by caveolin-1 and caveolin-3 status which is
independent of insulin signalling pathway. In addition, Chi et al.
has also reported the reduction in glucose levels on treatment
with RSV in which they demonstrated that RSV normalized
hepatic phosphoenolpyruvate carboxykinase and increased
Glut-4 expression in the soleus muscle of STZ diabetic rats [29]
AMPK is a mediator of glucose metabolism [17] and is found to
increase glucose transport by stimulating Glut-4 translocation
to the sarcolemma in the heart [30]. It was previously reported
that HepG2 cells treated with high glucose decreased phospho-
rylation of AMPK and its downstream target acetyl-CoA car-
boxylase (ACC) [31] and activation of AMPK by AICAR
increased the translocation of Glut-4 in skeletal muscle [32].
Nitric oxide is a biological messenger synthesized in mam-
malian cells and nitric oxide- dependent glucose transport in
skeletal muscle was reported after exercise-stimulation [33]. In
addition, it is shown that activated AMPK phosphorylates eNOS
on Ser1177 residue leading to NOS activation [34]. We have
observed increased phosphorylation of AMPK as well as eNOS
on RSV treatment as compared to diabetic group. At the basal
level, eNOS is located within the plasma membrane
microdomain caveolae and is negatively regulated by Cav-1. It
acts as a physiological inhibitor of eNOS [35] and Gustavsson
et al. has reported that during activation of endothelial cells the
caveolin-1 inhibitory clamp is diminished by the recruitment of
several proteins that promote an activation complex [36]. Bucci
et al. has demonstrated a significant increase in the expression of
Cav-1 in non-obese diabetic mice [11]. In skeletal muscle of eNOS
knockout mice, diminished insulin stimulated glucose uptake was
shown indicating the role of nitric oxide in glucose uptake [37].
In our present study, we have observed an increased expression
of Cav-1 in DM as compared to the control. However, there was a
subsequent decrease in Cav-1 expression upon RSV treatment in
the diabetic group. Moreover, immunoprecipitation of Cav-1 from
the membrane lipid raft fractions and re-blotting for eNOS showed
an increased Cav-1/eNOS association in the diabetic group which
was further evident from the reduced expression of phosphorylated
eNOS in the heavier cytosolic fractions in the diabetic group as com-
pared to the control. Upon RSV treatment we have observed
reduced Cav-1/eNOS association and increased phosphorylation of
eNOS in the diabetic group. Moreover, we have observed an
increased activation of AMPK in RSV treated group as compared to
the diabetic group. Therefore our data suggests that during diabetes
there is an increased association of Cav-1/eNOS in the lipid rafts
that makes eNOS unavailable for phosphorylation, but RSV treat-
ment alleviates the Cav-1/eNOS association, thereby releasing more
eNOS into the cytosol where it is phosphorylated by the active
AMPK, thus rendering eNOS more active in the treated myocardium.
Fig. 8 Represents the rat cardiac paraffin
sections labelled with immunofluorescence
and visualized using confocal microscopy
in control, DM and DM+RSV groups. A, D
and G represent red fluorescence labelled
Glut-4. B, E and H represent the green flu-
orescence labelled caveolin-3. C, F and I
represent the merged photo that clearly
shows the co-localization of caveolin-3 and
Glut-4. n = 6 in each group. White arrows
denote Glut-4, yellow arrows denote cave-
olin-3 and the white/yellow (merged) arrow
denotes the caveolin-3 and Glut-4 associa-
tion / co-localization. The number of
arrows represents the extent of expression
of either cav-3, Glut-4 or the extent of co-
localization of cav-3/Glut-4.
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We recently reported that increased nitric oxide production
during ischaemic preconditioning result in membrane transloca-
tion of Glut-4 and its association with Cav-3 [26]. As expected, we
have also observed increased Glut-4 translocation and its associ-
ation with Cav-3 upon RSV treatment as compared to STZ-
induced DM. We have also observed increased expression of Cav-
3 in RSV, and expression of Cav-3 was found to be necessary for
the activation of PI3-kinase and Akt [38]. Reduced activation of
both PI3-kinase and Akt in cells lacking Cav-3 expression has been
reported [38]. In addition, we have observed increased activation
of Akt in RSV-treated group as compared to DM. It is known fact
that insulin-induced translocation of Glut-4 to the surface involves
different signalling pathways like phosphorylation of insulin recep-
tor substrate-1, activation of PI3 kinase and serine/threonine
kinases like PKC and Akt/PKB [39]. Although the precise role of
Akt/PKB action in Glut-4 translocation remains to be determined,
reports show that phosphorylation and activation of Akt play an
essential role in insulin-stimulated Glut-4 translocation by involve-
ment in docking and / or fusion of Glut-4-containing vesicles with
the cell surface [40]. It is recently reported that PI3 kinase is
involved in the antihyperglycaemic effect of RSV and further
demonstrated RSV induced Akt phosphorylation is inhibited by
PI3 kinase inhibitors suggesting the role of activation of Akt in
Glut-4 translocation and reduced glucose uptake [29]. Glut-4
translocation and insertion into the plasma membrane has been
reported in adipocytes following Akt activation [41]. RSV-medi-
ated activation of Akt might have also played a significant role in
Glut-4 translocation and activation of glucose uptake. 
Thus, our result suggests that the effect of RSV is non-insulin
dependent and triggers some of the similar intracellular insulin
signalling components in myocardium such as eNOS, Akt through
AMPK pathway and also by regulating the caveolin-1 and caveolin-
3 status that might play an essential role in Glut-4 translocation
and glucose uptake in STZ- induced type-1 diabetic myocardium.
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